ベルギー -
英語 -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
ursodeoxycholic acid amdipharm 250 mg hard caps.
amdipharm ltd. - ursodeoxycholic acid 250 mg - capsule, hard - 250 mg - ursodeoxycholic acid 250 mg - liver therapy, lipotropics; a05aa02 ursodeoxycholic acid
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
de pharmaceuticals - ursodeoxycholic acid - oral tablet - 150mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
de pharmaceuticals - ursodeoxycholic acid - oral tablet - 300mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
wockhardt uk ltd - ursodeoxycholic acid - oral tablet - 300mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
alliance healthcare (distribution) ltd - ursodeoxycholic acid - oral tablet - 300mg
イギリス -
英語 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
a a h pharmaceuticals ltd - ursodeoxycholic acid - oral tablet - 300mg
欧州連合 -
英語 -
EMA (European Medicines Agency)
chenodeoxycholic acid leadiant (previously known as chenodeoxycholic acid sigma-tau)
leadiant gmbh - chenodeoxycholic acid - xanthomatosis, cerebrotendinous; metabolism, inborn errors - bile and liver therapy - chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.
マルタ -
英語 -
Medicines Authority
ursodeoxycholic acid aurobindo 250 mg capsules, hard
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hard capsule - ursodeoxycholic acid 250 mg - bile and liver therapy
オーストラリア -
英語 -
Department of Health (Therapeutic Goods Administration)
ursofalk ursodeoxycholic acid 500 mg tablet blister pack
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; purified talc; polysorbate 80; hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; macrogol 6000 - treatment of chronic cholestatic liver diseases
オーストラリア -
英語 -
Department of Health (Therapeutic Goods Administration)
urso ursodeoxycholic acid 500 mg tablet blister pack
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; polysorbate 80; crospovidone; purified talc; macrogol 6000; magnesium stearate; povidone; colloidal anhydrous silica; hypromellose - the treatment of chronic cholestatic liver diseases